Dr. William W. Chin is the Executive Vice President and Chief Medical Officer, PhRMA. A physician, an endocrinologist and an academic at heart, Dr. Chin’s vision includes establishing PhRMA as the premiere convener of those individuals who can serve as a catalyst for advancing drug discovery and development, regulatory sciences and collaborative partnerships.
In the past he served as Executive Dean for Research, Bertarelli Professor in Translational Medical Science Emeritus and Professor of Medicine Emeritus at Harvard Medical School (HMS). In this role, Dr. Chin had spearheaded efforts to design and implement the vision for research at HMS, with special emphasis on interdisciplinary and translational research that crosses departmental and institutional boundaries.
Dr. Chin is a Harvard-trained endocrinologist and longstanding faculty member. His impressive career is exemplified in part by his extensive bibliography of nearly 300 papers, chapters and books, most of which were generated during his 25 years on the Harvard Medical School faculty. During his tenure as a faculty member in the Department of Medicine at Brigham and Women’s Hospital, he became chief of the Genetics Division and a Howard Hughes Medical Institute investigator, advancing to professor of Medicine, and Obstetrics, Gynecology and Reproductive Biology at HMS. As a pioneering molecular endocrinologist at HMS, Dr. Chin embraced the early use of emerging DNA technology to make important discoveries regarding the structure, function and regulation of hormone genes. His investigations often demonstrated a translational research theme, connecting basic laboratory discoveries to their physiologic relevance in animal models and humans.
He has been honored with numerous awards for research, mentorship and leadership. Prior to HMS, Dr. Chin was at Eli Lilly and Company, where he worked as senior vice president for Discovery Research and Clinical Investigation.